Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus monotherapy versus tacrolimus + mycophenolate mofetil after kidney transplantation
NL-OMON46987Active, not recruiting
- Sponsor
- Nefro-NL
- Start
- Sep 2014
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in kidney allograft rejection comparing Tacrolimus monotherapy with Tacrolimus + mycophenolate mofetil (2 arms). Primary endpoints: Number of cytokine-producing alloreactive CD137+ T cells, Total number of infectious episodes and 3 more. Started Sep 2014; status: active, not recruiting.
02
Drugs
tacrolimusmycophenolate mofetil
03
Conditions
kidney allograft rejection
Beyond the preview
Go deeper on NL-OMON46987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46987.